QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ 1.66
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 fda-clears-incannex-to-proceed-with-phase-2-psilocybin-assisted-therapy-trial-for-anxiety

FDA approves Incannex's Phase 2 trial for psilocybin-assisted psychotherapy in treating generalized anxiety disorder, follo...

 incannex-to-launch-fda-approved-psilocybin-trial-for-anxiety-disorder-in-us-and-uk

Incannex Healthcare Inc. (NASDAQ:IXHL), (‘Incannex' or the ‘Company'), a clinical-stage pharmaceutical company developi...

 incannex-healthcare-files-for-offering-of-4m-common-shares-along-with-warrants-to-purchase-up-to-4m-common-shares

- SEC Filing

 fda-experts-weigh-in-on-incannexs-cannquit-o-with-feedback-on-cbd-as-treatment-for-opioid-use-disorder

Incannex Healthcare Inc., a cannabinoid and psychedelic medicine biotechnology company, announced the successful completion of ...

 psychedelic-assisted-therapy-advancements-create-a-new-horizon-for-mental-health-in-colorado

Psilocybin-assisted therapy shows promise in treating GAD. Denver trains first responders in psychedelic crisis intervention. H...

Core News & Articles

https://www.marijuanamoment.net/indiana-lawmakers-send-psilocybin-research-funding-bill-to-governor/   The Indiana legislatur...

 incannex-healthcare-tapped-treasurer-and-controller-joseph-swan-to-additional-role-of-cfo-effective-february-29-after-madhukar-bhalla-decided-to-retire

Madhukar Bhalla, Chief Financial Officer and Secretary of Incannex Healthcare Inc. (the “Company”), recently notified the Compa...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 whats-going-on-with-incannex-stock

Incannex said that its Phase 2 Psi-GAD1 clinical trial of psilocybin in generalized anxiety disorder met its primary endpoint o...

Core News & Articles

BYND: 105% | Beyond Meat shares are trading higher after the company reported mixed Q4 financial results. FLYW: 31% | Flywire ...

 incannex-announces-topline-results-from-phase-2-psi-gad1-clinical-trial-of-psilocybin-in-generalised-anxiety-disorder

Incannex Healthcare Inc. (NASDAQ:IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION